Filing Details

Accession Number:
0001140361-17-001563
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-11 16:30:14
Reporting Period:
2017-01-09
Filing Date:
2017-01-11
Accepted Time:
2017-01-11 16:30:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1572552 Asterias Biotherapeutics Inc. AST () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1457130 E. Katharine Spink 6300 Dumbarton Circle
Fremont CA 94555
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-01-09 2,878 $0.00 4,781 No 4 F Direct
Common Stock Disposition 2017-01-09 4,781 $4.60 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 7,659 Restricted Stock Units, the grant of which was previously reported on a Form 4.
  2. The shares sold were sold pursuant to a Rule 10b5-1 Plan adopted by the reporting person.